인쇄하기
취소

MOHW to approve NHI reimbursement for Iressa.

Published: 2004-02-11 07:00:00
Updated: 2004-02-11 07:00:00
The MOHW finally approved Iressa, a non-small cell lung cancer drug, for the NHI reimbursement in the 2nd NHI policy review panel on Feb. 6 for the treatment of non small cell lung cancer and the gamma knife operation of brain tumors. Accordingly, the NHI reimbursement will be granted from Mar. 1, 2004.

The NHI price for Iressa set up at 65,274 won, which was 88.4% and 87.2% of the price in...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.